STOCK TITAN

Humana (HUM) Stock Price, News & Analysis

HUM NYSE
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
15 252 sessions, November 10, 2025 to November 10, 2026
Largest daily move
-21.1% close of January 27, 2026
1-year change
+83.7% closing prices, November 10, 2025 to November 10, 2026
1-month change
+1.4% closing prices, October 9, 2026 to November 10, 2026

Company Description

Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry within the broader finance and insurance sector. According to the company, it is committed to putting health first for its teammates, customers and the organization, focusing on making it easier for the millions of people it serves to achieve their best health. Humana’s activities span insurance services and health care services, with a particular emphasis on people with Medicare, Medicaid, families, individuals, military service personnel and communities at large.

Humana’s core business includes private health insurance and government-sponsored health coverage. Humana is one of the largest private health insurers in the United States and has built a niche in Medicare, Medicaid and the military’s TRICARE program. AM Best describes Humana’s health and dental insurance subsidiaries collectively as Humana Health Group, and indicates that the group generates most of its earnings from its core Medicare Advantage segment, with additional premium from Medicaid managed care and supplementary lines such as dental and vision.

Business Segments and Services

Humana highlights two major pillars of its operations: Humana insurance services and CenterWell health care services. Through its insurance services, the company offers Medicare Advantage and other Medicare coverage options, Medicaid plans, and products for families, individuals and military service personnel. The company states that these offerings are designed to deliver the care and service people need, when they need it, with the goal of improving quality of life across its member base.

The company’s CenterWell segment is described by AM Best as a non-insurance business that provides a diversified source of revenue and earnings. CenterWell is mainly focused on building a value-based care platform through primary care, home care and pharmacy services operations. CenterWell Senior Primary Care and Conviva Senior Primary Care are senior-focused primary care providers that partner with organizations such as Thyme Care to support patients facing complex conditions like cancer. According to CenterWell’s own description, it is a health care services business focused on integrated, personalized experiences, including senior-focused primary care, home health care, and integrated home delivery, specialty, hospice and retail pharmacy services.

Focus on Government Programs and Value-Based Care

Humana’s medical membership is nearly all from Medicare, Medicaid and TRICARE. AM Best further explains that Humana Health Group generates most of its earnings from its individual Medicare Advantage segment and that its premium is rounded out by Medicaid managed care and supplementary lines. This concentration makes the organization sensitive to regulatory factors, but AM Best also notes that Humana maintains a favorable business profile and an excellent nationwide market position in its core lines of business.

Humana repeatedly emphasizes value-based care in its public communications. In its partnership with Atlas Oncology Partners for Medicare Advantage members in Tennessee and Mississippi, Humana describes coordinated, holistic care as core to its leadership in value-based care. The Atlas Oncology model integrates interdisciplinary care teams, care coordination, psychosocial support, and advanced supportive care to improve quality of life and reduce avoidable emergency or urgent care visits. Similarly, CenterWell’s collaboration with Thyme Care aims to provide continuous, integrated support for cancer patients, including 24/7 access to oncology-trained clinicians, navigation, symptom management and palliative care.

Medicare Advantage and Medicaid

Humana is active in Medicare Advantage (MA), which AM Best identifies as the company’s core business line and primary earnings driver. AM Best notes that Humana Health Group has experienced growth in MA premium revenue and that the company is pursuing margin re-stabilization in its individual MA segment. The company also offers Medicaid managed care through branded offerings such as Humana Healthy Horizons. Humana Healthy Horizons manages Medicaid benefits for more than 1.5 million members nationally under that brand, integrating physical health, behavioral health, pharmacy, long-term care and social services to support a whole-person approach for children, parents, childless adults and beneficiaries who are aged, blind or disabled.

Humana also participates in specialized Medicare Advantage offerings tailored to veterans. The Humana USAA Honor Giveback plans, co-branded with USAA Life Insurance Company, are designed with veterans in mind and provide Medicare Advantage coverage options that offer access to non-VA providers. These plans feature benefits such as a Part B giveback, $0 monthly plan premiums, $0 copays for in-network primary care visits, and coverage for dental, vision and hearing, along with $0 copays for in-network mental health services. While designed with veterans’ needs in mind, these plans are available to anyone eligible for Medicare in the covered service areas.

CenterWell and Care Delivery

CenterWell, a part of Humana, is described as a health care services business focused on creating integrated and differentiated experiences that put patients at the center. CenterWell is characterized as the largest provider of senior-focused primary care, one of the leading providers of home health care, and a provider of integrated home delivery, specialty, hospice and retail pharmacy. Its model emphasizes whole health, addressing physical, emotional and social wellness.

Through partnerships like the one with Thyme Care, CenterWell and Conviva extend primary care relationships into complex specialty care journeys. Thyme Care’s services for eligible CenterWell and Conviva patients include continuous support from oncology-trained nurse practitioners, nurses, social workers and care partners, access to community-based resources and social work support, and palliative and urgent care support designed to prevent unnecessary emergency visits and align treatment with patient goals and preferences.

Community and Philanthropic Initiatives

Humana’s activities extend beyond insurance and direct care delivery into philanthropy and community impact. The Humana Foundation, established as the philanthropic arm of Humana Inc., focuses on health equity and works to eliminate unjust, avoidable and unnecessary barriers in health and healthcare. It fosters evidence-based collaborations and investments that help people in underserved communities live connected, healthy lives. The Foundation emphasizes creating healthy emotional connections and shaping a healthier approach to nutrition to support lifelong well-being.

Recent work by the Humana Foundation includes research reports on issues such as loneliness among underserved boys and food insecurity among seniors in Kentucky. These reports highlight mental health challenges, disparities in suicide rates, and the relationship between food insecurity, emotional health and social connection. The Foundation identifies actions such as strategic communications, community-rooted outreach models, mentorship initiatives, peer mental health programs, and further research to address these challenges.

Humana also supports community initiatives through its Medicaid operations. Humana Healthy Horizons in Oklahoma, for example, has awarded Community Impact Awards to local organizations addressing urgent health-related social needs such as food insecurity, housing stability and employment opportunities. These awards are aligned with Oklahoma’s health priorities and the needs of Humana’s Medicaid population, based on health risk assessment data indicating high levels of financial strain and food insecurity among members.

Workforce and Professional Development

Humana’s communications indicate a significant nursing workforce and a focus on professional development. The company notes that it employs more than 10,000 nurses, including many in its CenterWell health care services division. Through a partnership with the Nurses on Boards Coalition, Humana is supporting a Mentoring for Success program that matches nursing students with nurse mentors employed by Humana. This initiative is intended to address the nursing shortage, support the pipeline of incoming nurses and develop current nurses as leaders through mentorship and governance-focused training.

Humana also invests in leadership development and succession planning within its insurance segment. An 8-K filing and related press release describe a planned transition in the role of Insurance Segment President, with a long-tenured executive moving into an advisory role and new leaders assuming responsibility for Medicare Advantage and the broader insurance segment. These disclosures underscore the company’s attention to continuity in its Medicare Advantage, Medicaid and specialty businesses.

Financial and Regulatory Profile

Humana’s common stock trades on the New York Stock Exchange under the symbol HUM. AM Best has affirmed the Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of “a” (Excellent) for Humana’s health and dental insurance subsidiaries, collectively referred to as Humana Health Group, with stable outlooks. AM Best assesses the group’s balance sheet strength as adequate and notes strong yet fluctuating operating results, influenced by trends in Medicare Advantage claims, regulatory payment rates, Star Ratings bonus payments and rebate revenue.

Humana’s SEC filings frequently reference non-GAAP measures such as Adjusted earnings per common share (Adjusted EPS), which management uses alongside GAAP EPS to analyze core operating performance, support planning and decision-making, and determine incentive compensation. The company provides reconciliations of GAAP EPS to Adjusted EPS in its 8-K filings when it issues or reaffirms earnings guidance, along with cautionary statements regarding forward-looking information.

Approach to Health and Well-Being

Across its insurance and health care services, Humana consistently frames its purpose as making it easier for people to achieve their best health. The company emphasizes delivering care and service when needed, improving quality of life for people with Medicare and Medicaid, families, individuals, military service personnel and communities. Through initiatives like value-based care partnerships in oncology, veteran-focused Medicare Advantage plans, community impact awards, and philanthropic research on mental health and food insecurity, Humana presents itself as addressing both clinical and social dimensions of health.

Stock Performance

$450.66
+2.88%
+12.59
Last updated: November 11, 2026 at 14:32
+83.7%
Performance 1 year
$54.1B

Humana (HUM) closed at $438.06 on November 10, 2026. Over the past 12 months, the price has gained 83.7%.

See what a $1,000 investment in HUM would be worth today

Average down calculator for HUM

HUM Metrics & Rankings

Price returns through November 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Humana has 10 recent news articles, with the latest published yesterday. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, dividends, partnership, earnings date. View all HUM news →

Financial Highlights

Humana generated $129.7B in revenue in FY2025, operating income reached $2.7B (2.1% operating margin), and net income was $1.2B, reflecting a 0.9% net profit margin. Diluted earnings per share stood at $9.84. The company generated $921.0M in operating cash flow. The current ratio was 2.00, measuring current assets divided by current liabilities.

$129.7B
Revenue (FY2025)
$1.2B
Net Income (FY2025)
$921.0M
Operating Cash Flow

Upcoming Events

NOV
16
November 16, 2026 Financial

Price determination

Reference Treasury yield-based price determination for Humana tender offers at 3:00 p.m. NYC time on Nov 16, 2026; may be extended.
NOV
16
November 16, 2026 Financial

Tender deadline

Tender and withdrawal deadline for Humana's cash offers at 5:00 p.m. NYC time on Nov 16, 2026; offers cover up to $1.5B principal.
NOV
18
November 18, 2026 Financial

Expected settlement

Expected settlement date for accepted tenders of Humana senior notes; accepted holders receive accrued interest through, excluding, settlement.
NOV
27
November 27, 2026 Financial

Quarterly cash dividend

Humana to pay a quarterly cash dividend of $0.885 per share on 2026-11-27 to holders of record as of 2026-10-30.
DEC
24
December 24, 2026 Financial

Dividend record date

Record date for Humana's $0.885 quarterly cash dividend; shareholders of record at close Dec 24, 2026 are eligible.
YEAR
2026
2026 Corporate

Advisor term end

Renaudin will serve as strategic advisor through at least the end of 2026
JAN
01
January 1, 2027 Product

2027 Medicare Advantage Plans

Plans effective Jan 1, 2027; available in ~2,600 counties across 45 states + DC; Chronic Condition SNPs expand into PA, UT, WI.
JAN
01
January 1, 2027 Operations

Illinois Medicaid go-live

Statewide Illinois Medicaid managed-care contract to go live on 2027-01-01; Humana sole new entrant among six awardees.
JAN
2027
January 2027 Operations

HealthChoice Illinois go-live

Statewide HealthChoice Illinois launch across 102 counties; Humana's plan goes live January 2027; no webcast listed.
JAN
29
January 29, 2027 Financial

Dividend payment

Quarterly cash dividend of $0.885 per share payable to holders of record on Dec 24, 2026; see Humana investor site for details.
YEAR
2056
2056 Financial

Junior subordinated notes due 2056

Junior subordinated notes maturing in 2056; $1.0B principal; 6.625% annual rate

Humana has 11 upcoming scheduled events. The next event, "Price determination", is scheduled for November 16, 2026 (in 5 days). 7 of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the HUM stock price.

Short Interest History

Last 12 Months

Short interest in Humana (HUM) currently stands at 2.8 million shares, down 24.2% from the previous reporting period, representing 2.3% of the float. Since November 2025, short interest has decreased by 34.5%.

Days to Cover History

Last 12 Months

Days to cover for Humana (HUM) currently stands at 2.1 days, up 8.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.7 to 6.9 days.

HUM Company Profile & Sector Positioning

Humana (HUM) operates in the Healthcare Plans industry within the broader Healthcare sector and is listed on the NYSE. Among dividend-paying stocks, HUM ranks #1,766 by dividend yield.

Investors comparing HUM often look at related companies in the same sector, including Centene Corporation (CNC), The Cigna Group (CI), Elevance Health, Inc. (ELV), CVS Health Corporation (CVS), and Molina Healthcare, Inc. (MOH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HUM's relative position within its industry.

Frequently Asked Questions

The current stock price of Humana (HUM) is $450.66 as of November 11, 2026.

The market cap of Humana (HUM) is approximately $54.1B. Learn more about what market capitalization means .

The FY2025 revenue of Humana (HUM) is $129.7B, from its most recent completed fiscal year.

The FY2025 net income of Humana (HUM) is $1.2B, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Humana (HUM) is $9.84 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Humana (HUM) is $921.0M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Humana (HUM) is 0.9% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Humana (HUM) is 2.1% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The current ratio of Humana (HUM), current assets divided by current liabilities, was 2.00 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Humana (HUM) is $2.7B for FY2025, its most recent completed fiscal year. Learn about operating income.